- Aspergillus Fumigatus (1)
- Aspergillus Fumigatus
- Immunoglobulin IgE (1)
- Immunoglobulin IgE
ABPA Screen (Allergic Bronchopulmonary Aspergillosis) – Early Detection of Aspergillosis-Related Allergic Lung Condition
Are you or your loved ones experiencing recurring respiratory symptoms such as wheezing, coughing, and difficulty breathing? The ABPA Screen is a specialized test designed to detect the presence of Allergic Bronchopulmonary Aspergillosis (ABPA), an allergic lung condition caused by an immune response to the fungus Aspergillus.
Allergic Bronchopulmonary Aspergillosis (ABPA) primarily affects individuals with asthma or cystic fibrosis. Aspergillus, a common environmental fungus, triggers an exaggerated immune response in the lungs, leading to inflammation and airway obstruction.
The ABPA Screen involves assessing specific antibodies and immune markers associated with ABPA. Early detection of this condition is crucial, as untreated ABPA can lead to worsening lung function and severe respiratory complications.
Our experienced medical team performs the ABPA Screen with precision and efficiency, providing you with accurate results and expert guidance on the next steps. If diagnosed with ABPA, appropriate management strategies can be initiated, including antifungal medications, corticosteroids, and allergy management.
Don’t let respiratory symptoms compromise your quality of life. The ABPA Screen offers a proactive approach to identifying and managing ABPA, helping you breathe easier and enjoy a healthier life.
Take charge of your respiratory health with the ABPA Screen – your first step toward effective management of Allergic Bronchopulmonary Aspergillosis.